Business News:

Do you have a press release about your business? There is no need for you to pay us for posting your press release - you can post for free right now. More »

Breaking News:

You can even break news here as well. More »

Medical News:

Press Releases relating to medical news. More »

Sign up today!

Before you can do anything you need to sign up! More »

Post your press release here

Post your press release here and promote your resource More »

 

Pharmaceutical Hot Melt Extrusion Market Trends And Opportunities For The Industry By 2024

Global Pharmaceutical Hot Melt Extrusion Market: Overview

This report provides forecast and analysis of the pharmaceutical hot melt extrusion market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn) and volume (units). The report also includes macroeconomic indicators along with an outlook on hot melt extrusion equipment consumption globally. It includes drivers and restraints of the market and their impact on each region during the forecast period.

This 164 page report gives readers a comprehensive overview of the pharmaceutical hot melt extrusion market. Browse through 18 data tables and 99 figures to unlock the hidden opportunities in this market:

http://www.transparencymarketresearch.com/pharmaceutical-hot-melt-extrusion-market.html

The report also comprises the study of current issues with end users and opportunities for extruder manufacturers. It also includes detailed pricing analysis by product type and value chain analysis with a list of vendors and industry stakeholders at each node in the value chain. In order to provide users of this report with comprehensive view of the market, we have included detailed competitiveness analysis and company players with unique selling propositions. The dashboard provides detailed comparison of hot melt extruder manufacturers on parameters such as collective market share and geographic concentration. The study encompasses market attractiveness analysis, by product, by end users and region.

Global Pharmaceutical Hot Melt Extrusion Market: Scope of the Study

The report includes revenue generated from sales of hot melt extruders in all regions and important countries in these regions. By product, the global market has been segmented into twin screw extruder, single screw extruder, laboratory extruders and RAM extruders. On the basis of end users, the global market is segmented into research laboratories, contract manufacturing organizations and pharma companies. On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Market numbers have been estimated based on average procurement of new units and average pricing of hot melt extruders by product type and the revenue is derived through regional pricing trends. Market size and forecast for each segment have been provided in the context of global and regional markets. The pharmaceutical hot melt extrusion market has been analyzed based on expected demand. Prices considered for the calculation of revenue are average regional prices obtained through primary quotes from numerous regional hot melt extruder manufacturers and distributors. Most of the key end users have been considered and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving pharmaceutical hot melt extrusion market during 2016 -2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19961

Regional demand patterns have been considered while estimating the market for various end users of hot melt extrusion in different regions. Top-down approach has been used to estimate the hot melt extrusion market by regions. Market numbers for global products have been derived using the bottom-up approach, which is cumulative of each region’s demand. Company-level market share has been derived on the basis of revenues reported by key manufacturers. The market has been forecast based on constant currency rates. A number of primary and secondary sources were consulted during the course of the study. Secondary sources include Factiva, NCBI, Google books, company annual reports, websites, and publications.

Companies Mentioned in the Report

The report provides detailed competitive dashboard and company profiles of key participants operating in the global market. Some of the players in the global pharmaceutical hot melt extrusion market includes Baker Perkins Limited, Coperion GmbH, Gabler GmbH & Co. KG, Leistritz AG, Milacron Holdings Corp., Thermo Fisher Scientific, Inc., and Xtrutech Ltd.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Share Button

Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devices to Remain High among Asthma Patients

Global Pulmonary Drug Delivery Devices Market: Overview

This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.

This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global pulmonary drug delivery devices market with respect to the leading market segments based on major products, key applications, distribution channels, and geographies.

This 238 page report gives readers a comprehensive overview of the pulmonary drug delivery devices market. Browse through 42 data tables and 86 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html

Global Pulmonary Drug Delivery Devices Market: Segmentation

The global pulmonary drug delivery devices market has been studied based on major product type, application segments, major distribution channels, and regional as well as national markets. Based on product type, the global market has been categorized into three major segments: Dry Powder Inhalers, Metered Dose Inhalers and Nebulizers. Based on application, the global market has been categorized into four segments: Asthma, COPD, cystic fibrosis, and others. Based on distribution channels, the global market has been categorized into three key segments: retail pharmacies, hospital pharmacies, and e-commerce.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global pulmonary drug delivery devices market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products / applications / distribution channels / geographies.

Global Pulmonary Drug Delivery Devices Market: Regional Overview

Geographically, the pulmonary drug delivery devices market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). Each regional market for pulmonary drug delivery devices market has been further categorized into major product, application, and end-user segments considered within the scope of the study.

Key country (U.S., Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving pulmonary drug delivery devices market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=873

Global Pulmonary Drug Delivery Devices Market: Competitive Outlook

The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the pulmonary drug delivery devices market report. The section also includes competition matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global pulmonary drug delivery devices market.

The report also profiles key players operating in the pulmonary drug delivery devices market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include AstraZeneca plc, Novartis AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Merck & Co., Inc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, 3M Healthcare, Omron Corporation, and others.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Share Button

Medical Oxygen Concentrators Market: Geriatric and COPD Population in North America Puts Region in Lead

Global Medical Oxygen Concentrators Market: Overview

Medical oxygen concentrators are used by patients suffering from COPD and other respiratory diseases. Patients having low level of oxygen in their blood are prescribed to use oxygen concentrators. Oxygen concentrators are to be used only with prescription and cannot be purchased over the counter. Medical oxygen concentrators work either on rechargeable lithium batteries or by continuous electric supply. The medical oxygen concentrators are produces oxygen from the surrounding air. It works on the principle of compression of air by which the concentrators are prevented from overheating. After taking the air from the surrounding nitrogen is removed through the air filters and with adjusted delivery rate purifies oxygen is delivered to the patients with the help of nasal cannula or mask. The global medical oxygen concentrators market is segmented by modality, technology, end users and geography. By modality the global medical oxygen concentrator market is further segmented into portable oxygen concentrators and stationary oxygen concentrators. According to technology the market is segmented further by pulse flow technology and continuous flow technology. By end users the market is segmented into hospitals, home care and ambulatory surgical centers. In terms of geography the global medical oxygen concentrators market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

This 171 page report gives readers a comprehensive overview of the Medical Oxygen Concentrators Market. Browse through 24 data tables and 70 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/medical-oxygen-concentrators-market.html

Global Medical Oxygen Concentrators Market: Research Methodologies

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the medical oxygen concentrator market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for each by modality, technology, end user, and geography for the period 2014 to 2024, considering the macro and micro environmental factors. The revenue generated from each product was calculated by considering number of products used in the procedures and their market demand as per their use, prevalence rate of disease, number of product launched, annual revenue generated by products of each sub segment, trends in industry, end user trend, and adoption rate across all the geographies.

Global Medical Oxygen Concentrators Market: Scope of the Study

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on modality, technology, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the medical oxygen concentrators market in the current and future scenario.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The study also covers detailed country analysis contributing majorly in the monoclonal antibody therapeutics market.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Medical Oxygen Concentrators Market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3998

Global Medical Oxygen Concentrators Market: Competitive Landscape

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the monoclonal antibody therapeutics market are Chart Industries, Inc., Inogen, Inc., Invacare Corporation, Koninklijke Philips N.V., Resmed Inc., Drive DeVilbiss Healthcare LLC., Precision Medical, Inc., Besco Medical Co. Ltd., O2 Concepts LLC, GCE Group and others.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Share Button

Vial Adaptors for Reconstitution Drug Market: Rising Incidence of Infectious Diseases Augments Demand for Market

Vial Adaptors for Reconstitution Drug Market: Scope and Methodology

This report on the vial adaptors for reconstitution drug market analyzes the current and future prospects of the market globally. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn and volume in terms of million units for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global vial adaptors for reconstitution drug market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

This 155 page report gives readers a comprehensive overview of the vial adaptors for reconstitution drugs market. Browse through 28 data tables and 58 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/vial-adaptors-for-reconstitution-drug-market.html

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global vial adaptors for reconstitution drug market.

Market revenue in terms of US$ Mn and volume in terms of million units for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of cancer and other chronic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Vial Adaptors for Reconstitution Drug Market: Segmentation

Based on product type, the global vial adaptors for reconstitution drug market has been segmented into 13mm vial adaptor and 20mm vial adaptor. The market has been further studied from the point of view of major material. Based on material, the market has been categorized into polycarbonate, silicon, polyethylene teraphthalate glycol, polyethylene, and others. On the basis of therapeutic area, the market has been segmented autoimmune diseases, infectious diseases, metabolic conditions, reproductive health and others. On the basis of delivery mode, the market has been segmented injection and infusion.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving vial adaptors for reconstitution drugs market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18509

Vial Adaptors for Reconstitution Drug Market: Geographical and Competitive Dynamics

Geographically, the global vial adaptors for reconstitution drug market has been segmented into five regions: North America, Europe, Asia Pacific, and Rest of World. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, China, and Japan.

Key Players Mentioned in the Report are:

The global vial adaptors for reconstitution drug market is consolidated in which relatively small number of companies accounted for majority market share. Major players operating in the global vial adaptors for reconstitution drug market are Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Sensile Medical AG, Unilife Corporation and West Pharmaceutical Services, Inc.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Share Button

Multiplexed Diagnostics Market is projected to reach US$26.36 bn by the end of 2024

Global Multiplexed Diagnostics Market: Snapshot

The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations. However, the global multiplexed diagnostics market is being restrained by high costs pertaining to multiplexed diagnostics assay equipment and testing and an overall lack of skilled labor for handling the advanced equipment.

This 194 page report gives readers a comprehensive overview of the multiplexed diagnostics market. Browse through 24 data tables and 75 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/multiplexed-diagnostics-market.html

The global multiplexed diagnostics market was valued at US$5.0 bn in 2015. It is projected to reach US$26.36 bn by the end of 2024 after expanding at a CAGR of 20% from 2016 to 2024.

North America’s Dominance in Global Multiplexed Diagnostics Market to Continue

The global Multiplexed diagnostics market is segmented on the basis of regions, into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2015, North America bagged for the leading share of the market in terms of value, owing to a rising prevalence of cardiac diseases and cancer in the region. North American players in the multiplexed diagnostics market also benefitted from the greater level of penetration of the national health care services. The region is expected to continue dominating the global multiplexed diagnostics market till 2024, a likelihood attributed to the region’s high percentage of the geriatric population, an advanced and structured healthcare industry, and a large scope of application of reimbursement policies from both public and private sources.

In Europe, the market for multiplexed diagnostics is also expected to grow at a substantial rate with the growing involvement of academic and research institutes from Germany and the U.K. North America and Europe are projected to be highly lucrative markets for players from the global multiplexed diagnostics market. Conversely, multiplexed diagnostics have not yet found solid foundations in Latin America, Asia Pacific, and the Middle East & Africa to grow on for now.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving multiplexed diagnostics market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1719

Infectious Disease Diagnostics in Full Swing

In terms of applications, the global multiplexed diagnostics market can be divided into autoimmune diseases, oncology, cardiac diseases, infectious disease diagnostic, and allergies. In 2015, a collective lead was attributed to the two segments of infectious disease diagnostics and oncology, due to an increase in the prevalence of infectious diseases along with a growing count of patients suffering from breast cancer, colorectal cancer, and prostate cancer. Oncology, cardiac diseases, and infectious disease diagnostics are expected to be highly beneficial segments for players from the global multiplexed diagnostics market. The segment for cardiac diseases is expected to expand at leading rate over the coming years due to the growing prevalence of various cardiovascular diseases. In terms of end users, the global multiplexed diagnostics market was led by academic research institutes in 2015. It is also expected to be the dominant end user in the market till 2024, owing to an increasing contribution of universities and cancer research centers and the research projects in the field of genetic engineering.

Till 2015, the leading players in the global multiplexed diagnostics market included Agilent Technologies, Bio-Rad Laboratories, Inc., BioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Luminex Corporation, Hologic, Inc., Thermo Fisher Scientific, Inc., Siemens Healthineers, and Abbott Laboratories.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Share Button
'
23P-CH8D-XH8X-DC9A-CLR7